G. Carpagnano (Bari, Italy), P. Sterk (Amsterdam, Netherlands)
Late Breaking Abstract - Genetic diagnosis of alpha-1 antitrypsin deficiency using saliva samples
A. Larruskain (Derio , Spain), A. Buxens (Derio , Spain), M. López (Derio , Spain), M. Artieda (Derio , Spain)
|   |
Late Breaking Abstract - The roles of impulse oscillometry in detection of asthma control level.
W. Chaiwong (Chiang Mai, Thailand), S. Namwongprom (Chiang Mai, Thailand), C. Liwsrisakun (Chiang Mai, Thailand), C. Pothirat (Chiang Mai, Thailand)
| |
Cross-sectional biomarker comparisons with a longitudinal perspective in asthma monitoring: the eNose premise
M. Ibrahim (Amsterdam, Netherlands), R. De Vries (Amsterdam, Netherlands), A. Lammers (Amsterdam, Netherlands), B. Xu (Bordeaux, France), . Neerincx (Amsterdam, Netherlands), S. Vijverberg (Amsterdam, Netherlands), Y. Dagelet (Amsterdam, Netherlands), A. Kraneveld (Utrecht, Netherlands), U. Frey (Basel, Switzerland), R. Lutter (Amsterdam, Netherlands), P. Sterk (Amsterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), A. Sinha (Amsterdam, Netherlands)
| |
Characteristics of patients with physician-assigned COPD without airflow obstruction in NOVELTY
A. Agustí (Barcelona, Spain), R. Hughes (Cambridge, United Kingdom), R. Del Olmo (Buenos Aires, Argentina), J. Vestbo (Manchester, United Kingdom), B. Make (Denver, CO, United States of America), E. Rapsomaniki (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), D. Price (Aberdeen, United Kingdom)
| |
Determinants of arterial stiffness in Alpha-1 Antitrypsin Deficiency
A. Gassama (Birmingham (West Midlands), United Kingdom), L. Sapey (Birmingham (West Midlands), United Kingdom), D. Griffiths (Birmingham (West Midlands), United Kingdom), R. Stockley (Birmingham (West Midlands), United Kingdom), P. Kumar (Birmingham (West Midlands), United Kingdom), A. Turner (Birmingham (West Midlands), United Kingdom)
| |
Comparison of the lung ventilation assessed by a full-scale airway network flow model and xenon-enhanced dual-energy CT of patients with COPD
M. Kim (Loughborough, United Kingdom), O. Doganny (Izmir, Turkey), H. Hwang (Seoul, Republic of Korea), J. Seo (Seoul, Republic of Korea), F. Gleeson (Oxford, United Kingdom)
| |
Comparison of low-dose CT image registration-based “Parametric Response Maps” with global lung function and diffusion capacity in COPD patients
S. Bayat (Grenoble, France), L. Broche (Grenoble, France), M. Machichi (Grenoble, France), S. Bailly (Grenoble, France), B. Degano (Grenoble, France), R. Tamisier (Grenoble, France), G. Ferretti (Grenoble, France), J. Pépin (Grenoble, France)
| |
Effect of age, gender and body habitus upon exhaled breath volatiles in COPD and health
L. Carr (Leicester (Leicestershire), United Kingdom), M. Yavari Ramsheh (Leicester (Leicestershire), United Kingdom), L. Bryant (Leicester (Leicestershire), United Kingdom), A. Yousef (Leicester (Leicestershire), United Kingdom), R. Cordell (Leicester (Leicestershire), United Kingdom), M. Wilde (Leicester (Leicestershire), United Kingdom), S. Siddiqui (Leicester (Leicestershire), United Kingdom), P. Monks (Leicester (Leicestershire), United Kingdom), C. Brightling (Leicester (Leicestershire), United Kingdom)
| |
New method of Alpha-1-antitrypsin diagnosis facilitates the detection of rare mutations
A. Klemmer (Marburg, Germany), M. Veith (MarburgMarburg, Germany), J. Tüffers (MarburgMarburg, Germany), E. Peychev (MarburgMarburg, Germany), C. Berndt (MarburgMarburg, Germany), V. Kotke (MarburgMarburg, Germany), C. Herr (Homburg/Saar, Germany), R. Bals (Homburg/Saar, Germany), C. Vogelmeier (MarburgMarburg, Germany), T. Greulich (MarburgMarburg, Germany)
| |
Factors associated with physician assessment of severity of asthma or COPD in NOVELTY
A. Papi (Ferrara, Italy), H. Reddel (Sydney, Australia), A. Agustí (Barcelona, Spain), G. Anderson (Victoria, Australia), A. Bansal (Cambridge, United Kingdom), R. Beasley (Wellington, New Zealand), E. Bel (Amsterdam, Netherlands), C. Janson (Uppsala, Sweden), B. Make (Denver, CO, United States of America), I. Pavord (Oxford, United Kingdom), D. Price (Aberdeen, United Kingdom), E. Rapsomaniki (Cambridge, United Kingdom), D. Finch (Cambridge, United Kingdom), M. Alacqua (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), R. Hughes (Cambridge, United Kingdom)
| |
Antecedent hospitalization history of patients newly diagnosed with COPD
F. Baty (St. Gallen, Switzerland), M. Hagmann (St. Gallen, Switzerland), F. Rassouli (St. Gallen, Switzerland), M. Brutsche (St. Gallen, Switzerland)
| |
Update on CADSET (Chronic Airway Disease Early Stratification) Clinical Research Collaboration
M. Faner Canet (Barcelona, Spain), G. Donaldson (London, United Kingdom), E. Heuvelin (Lausanne, Switzerland), V. Szabo (Barcelona, Spain), R. Breyer-Kohansal (Vienna, Austria), E. Melén (Stockholm, Sweden), A. Maitland-Van Der Zee (Amsterdam, Netherlands), J. Vestbo (Manchester, United Kingdom), J. Allinson (London, United Kingdom), L. Vanfleteren (Gothenburg, Sweden), M. Van Den Berge (Groningen, Netherlands), I. Adcock (London, United Kingdom), L. Lahousse (Ghent, Belgium), J. Wedzicha (London, United Kingdom), A. Agusti (Barcelona, Spain)
| |
Are T2 biomarkers of any help in diagnosing asthma?
H. Nekoee Zahraei (Liege, Belgium), F. Schleich (Liege, Belgium), E. Graulich (Liege, Belgium), M. Henket (Liege, Belgium), V. Paulus (Liege, Belgium), F. Guissard (Liege, Belgium), A. Donneau (Liege, Belgium), R. Louis (Liege, Belgium)
| |
Diaphragmatic movement in COPD patients in rest and after physical activity
E. Mekov (Sofia, Bulgaria), N. Yanev (Sofia, Bulgaria), N. Kurtelova (Sofia, Bulgaria), A. Tsakova (Sofia, Bulgaria), R. Petkov (Sofia, Bulgaria)
| |
Hidden morbidity of asthma in primary care: the results of a community outreach programme
M. Crooks (Hull [East Yorkshire], United Kingdom), J. Thompson (Hull [East Yorkshire], United Kingdom), H. Cummings (Hull [East Yorkshire], United Kingdom), N. Jackson (Hull [East Yorkshire], United Kingdom), K. Watkins (Hull [East Yorkshire], United Kingdom), S. Faruqi (Hull [East Yorkshire], United Kingdom)
| |
Comparison of individual items of COPD Assessment Test (CAT) at baseline in the EMAX and IMPACT trials
P. Jones (Brentford, Middlesex, United Kingdom), M. Dransfield (Birmingham, AL, United States of America), I. Boucot (Brentford, Middlesex, United Kingdom), E. Kerwin (Medford, OR, United States of America), D. Lipson (Collegeville and Philadelphia, PA, United States of America), C. Vogelmeier (Marburg, Germany), M. Han (Ann Arbor, MI, United States of America), L. Bjermer (Lund, Sweden), R. Wise (Baltimore, MD, United States of America), F. Maltais (Québec, QC, Canada), L. Tombs (Stockley Park, Uxbridge, Middlesex, United Kingdom), S. Kilbride (Stockley Park, Uxbridge, Middlesex, United Kingdom), C. Compton (Brentford, Middlesex, United Kingdom), F. Martinez (New York, NY, United States of America)
| |
Systematic assessment detects respiratory problems in illness-susceptible athletes
J. Hull (London, United Kingdom), A. Jackson (London, United Kingdom), C. Ranson (London, United Kingdom), M. Loosemore (London, United Kingdom)
| |
Predicting frequent exacerbations in a severe asthma centre.
C. Green (Birmingham, United Kingdom), A. Bahron (Birmingham, United Kingdom), J. Marsh (Birmingham, United Kingdom), A. Mansur (Birmingham, United Kingdom)
| |